Here’s the press release.
(STARES at today’s news)
*^()&)*(&)*(&)*( I DON’T EVEN.
(RUNS around yelling incoherently, but happily.)
THIS… this is what we’ve been waiting for. Ocata is officially now going to start Phase 2 of the AMD study.
There’s so much to be said here… it’ll have to get done later on… but for now… HAPPY. Just plain… happy. 🙂
I’m on the last day of vacation, so there won’t be a long post about this one, but basically… Ocata now has not one but TWO extremely recent NIH grants. This one is for Retinitis Pigmentosa. Now, I’m going to make a shameful admission… I’m an America’s Next Top Model addict. ;)ANTM doesn’t make it onto science blogs too often (or even science-y layperson blogs), but there’s a good reason here. Back in the fourth season, there was a contestant named Amanda. She was slowly going blind from Retinitis Pigmentosa, which is why I think the judges didn’t allow her to win. It was a very sad story and actually makes it hard to watch reruns of that season. By this time, I think she’s gone completely blind. But this grant shows that there is hope for her and everyone else who has the same terrible condition.
Anyway, check out the story:
Ocata Therapeutics Receives SBIR Grant from the NIH’s National Eye Institute to Develop Proprietary Photoreceptor Progenitor Cell Therapy for Retinitis Pigmentosa
So, I was posting a summary for my book on the NaNoWriMo Facebook page, thinking that it sounded over the top… stem cell-based cures for horrible incurable diseases within 2-10 years, that kind of thing… well….
There’s no link for this, because it is insider info from shareholders who went to Ocata’s quarterly meeting in Boston, which was not open to the public. (There is a LOT about Ocata in the book– they’re the biotech company that just changed their name from Advanced Cell Technology.) Ocata is the company developing the first cure (or even treatment!) for age-related macular degeneration, a disease that slowly causes blindness for 30 million people in the U.S. and Europe alone. The interim published results for the clinical trials have looked great, but as far as when this treatment might actually come to market… it’s everybody’s guess.
But in the quarterly meeting… several attendees have all said the same thing. The drug already has orphan treatment approval for a genetic disease caused Stargardt’s, which has exactly the same effects and eventually causes blindness. But it attacks much younger people, including children as young as six. (Yep, six years old.) AND… the CEO of Ocata said that the drug will be available in the U.K. in 2018. We don’t have absolute confirmation of this yet. But it’s apparently what was officially said at that meeting.
One of the lines of thought on the forums is that the date might be earlier for AMD approval in the U.S, even quite a bit earlier if the drug is fast tracked here… we just don’t know. But this is INCREDIBLE!!!~ There has never ever been any kind of treatment for Stargardt’s before, and now there will be, and it will be STEM CELL BASED. As of now, that will be the first drug approved anywhere in the WORLD that is embryonic stem cell based.
YES! IT’S THE START OF A NEW ERA IN MEDICINE!!! And it will be in the book!
(sorry about the capslock…
Posted in Great News
Tagged advanced cell technology, amd, cure for blindness, cures, embryonic stem cells, investigational drugs, miracles, ocata, robert lanza, stargardt, stargardt's, stem cell, stem cells, treatments, trials
There are a lot of stem cell blogs out there, some of them better than others… a LOT better. and some a lot worse. 😛 Paul Knoepfler’s blog is one of those at the head of the pack for sure, although I don’t always agree with everything he’s been publishing lately, especially the glowing, overly optimistic, heading-for-a-fall-IMHO coverage of Takahashi and her iPSC cell based RPE work in Japan. (You know, the one where they’re moving terrifyingly fast and using humans as guinea pigs about a zillion times faster than they should have…) But anyway. We all have our own opinions. 🙂
It’s also good to branch out. And that’s why I’m recommending this link to msemporda’s blog!
The Amazing Stem Cell Science Blog. THIS, I tell you, is an expert. Stem cell science, sector analysis, biotech company analysis, news… he has it all. And he’s somehow able to keep from rants…. I can’t do that, and I admit it… So check it out. 🙂
Posted in Uncategorized
Tagged advanced cell technology, amd, induced pluripotent stem cells, ipsc, japan, msemporda, paul knoepfler, rant, Riken, stem cell blogs, stem cells, takahashi
Stem cells. The hope, the hype; the successes, the failures; the frauds, the triumphs, and the miracles in the making. It’s all going to be here! Oh, okay; ALL of the information in the world about stem cells is probably NOT going to be found here. 😉 But if I can find it out… will be. There will be much more content here, including the story of just why and how I became so passionate about the entire issue of stem cells and regenerative medicine. I can honestly say that some of what you’ll read here is unique and cannot be found anywhere else the world. So just keep watching this space– some incredible things are coming up!